PARAMETRIC PORTFOLIO ASSOCIATES LLC - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 26 filers reported holding PSYCHEMEDICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q1 2022$119,000
+30.8%
17,270
+32.5%
0.00%
Q4 2021$91,000
-26.6%
13,033
-11.8%
0.00%
Q3 2021$124,000
+27.8%
14,769
+6.4%
0.00%
Q2 2021$97,000
+6.6%
13,886
-5.8%
0.00%
Q1 2021$91,000
+65.5%
14,745
+17.2%
0.00%
Q3 2020$55,000
-9.8%
12,581
+24.9%
0.00%
Q1 2020$61,000
-33.7%
10,0720.0%0.00%
Q4 2019$92,00010,0720.00%
Other shareholders
PSYCHEMEDICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 40,001$276,0000.13%
SANTA MONICA PARTNERS LP 20,000$138,0000.10%
Invenomic Capital Management LP 135,631$769,0000.08%
Cannell Capital 78,306$540,0000.08%
RBF Capital, LLC 144,231$996,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 266,502$1,839,0000.04%
Ancora Advisors LLC 80,728$557,0000.01%
HighMark Wealth Management LLC 2,039$14,0000.01%
Renaissance Technologies 341,422$2,356,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 34,618$240,0000.00%
View complete list of PSYCHEMEDICS CORP shareholders